ArticleThe patient2026

Factors influencing Patient Preferences for BRCA Testing and Adjuvant Therapy in HER2-Negative Early Breast Cancer in the United States: Best-Worst Scaling and Discrete Choice Experiment.

Kathryn Mishkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.